• Profile
Close

Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: Trachelectomy vs hysterectomy

American Journal of Obstetrics and Gynecology Aug 26, 2018

Machida H, et al. - Reproductive-aged women who underwent trachelectomy for early-stage cervical cancer were compared to those who had hysterectomy in terms of characteristics and survival. Findings suggest a significant increase in the proportion of reproductive-aged women with stage IA or IB1 (≤ 2cm) cervical cancer who underwent trachelectomy in recent years. In this population, trachelectomy led to survival outcomes comparable to those who had hysterectomy.

Methods

  • Between 1998 and 2014, researchers performed a retrospective observational study examining the Surveillance, Epidemiology, and End Results Program.
  • They compared women less than 45 years of age with stage IA and IB1 (tumor size ≤2 cm) cervical cancer who underwent trachelectomy vs those who underwent hysterectomy.
  • Clinico-pathological factors associated with trachelectomy were identified using multivariable models.
  • The two groups were compared regarding survival after propensity score matching.

Results

  • Researchers recruited 6,359 women in this study; of these, 190 (3.0%, 95% confidence interval [CI] 2.6-3.4) underwent trachelectomy.
  • The trachelectomy group had the median age of 31 years (inter-quartile range, 28-34).
  • During the study period, a significant increase in the proportion of women who underwent trachelectomy was noted (1.2% in 1998-2002, 3.0% in 2003-2008, and 4.5% in 2009-2014, P < 0.001).
  • Independent factors associated with trachelectomy use included younger age, non-black race, single marital status, Eastern registry area, recent disease diagnosis, non-squamous histology, and higher stage (all, adjusted-P < 0.05).
  • The trachelectomy group and the hysterectomy group were similar in terms of 5-year cause-specific survival (96.9% vs 96.6%, hazard ratio 0.73, 95% CI 0.23-2.30, P=0.59) and overall survival (96.1% vs 96.6%, hazard ratio 0.76, 95% CI 0.26-2.20, P=0.61) after propensity score matching.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay